| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8478481 | Molecular and Cellular Neuroscience | 2016 | 29 Pages |
Abstract
The Rho/Rho kinase (ROCK) pathway serves as molecular switches in many biological processes including the immune response. ROCK inhibitors lead to amelioration of some autoimmune diseases. The present study was designed to define whether a selective ROCK inhibitor, fasudil, was effective in experimental autoimmune myasthenia gravis (EAMG) and investigate the underlying mechanisms. Here we found fasudil effectively attenuated the development of ongoing EAMG. Fasudil abolished the antibody production and function by decreasing follicular helper T cells and CD19+ B cells, especially germinal center B cells. Moreover, fasudil reduced the expression of CD80 on lymph node mononuclear cells. These findings suggest the inhibition of ROCK might be a potential therapeutic strategy for antibody-mediated autoimmune diseases.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Heng Li, Min Zhang, Cong-Cong Wang, Xiao-Li Li, Peng Zhang, Long-Tao Yue, Shuai Miao, Ying-Chun Dou, Yan-Bin Li, Rui-Sheng Duan,